首页 > 最新文献

International Journal of Rheumatic Diseases最新文献

英文 中文
Case Report: Fulminant Lupus Myocarditis With Concomitant Pulmonary Infarction 病例报告:暴发性狼疮性心肌炎伴发肺梗塞。
IF 2 4区 医学 Q2 RHEUMATOLOGY Pub Date : 2026-01-01 DOI: 10.1111/1756-185x.70525
Beyza Parlatır, Adam Türk, Safiye Bakkal, Semih Gülle
{"title":"Case Report: Fulminant Lupus Myocarditis With Concomitant Pulmonary Infarction","authors":"Beyza Parlatır, Adam Türk, Safiye Bakkal, Semih Gülle","doi":"10.1111/1756-185x.70525","DOIUrl":"10.1111/1756-185x.70525","url":null,"abstract":"","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"29 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145878369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SONK-Like Subchondral Osteonecrosis Associated With Immune Checkpoint Inhibition sonk样软骨下骨坏死与免疫检查点抑制相关。
IF 2 4区 医学 Q2 RHEUMATOLOGY Pub Date : 2025-12-31 DOI: 10.1111/1756-185x.70532
Wan-Hao Tsai, Ko-Jen Li
{"title":"SONK-Like Subchondral Osteonecrosis Associated With Immune Checkpoint Inhibition","authors":"Wan-Hao Tsai, Ko-Jen Li","doi":"10.1111/1756-185x.70532","DOIUrl":"10.1111/1756-185x.70532","url":null,"abstract":"","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"29 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145862908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paraneoplastic Amyopathic Dermatomyositis Suspect by Nailfold Capillaroscopy in a Patient With Breast Carcinoma 甲襞毛细血管镜检查怀疑患有乳腺癌的副肿瘤性淀粉性皮肌炎。
IF 2 4区 医学 Q2 RHEUMATOLOGY Pub Date : 2025-12-27 DOI: 10.1111/1756-185x.70528
Farzana Shumy, Minhaj Rahim Choudhury, Zahid Amin, Kotaro Matsumoto
{"title":"Paraneoplastic Amyopathic Dermatomyositis Suspect by Nailfold Capillaroscopy in a Patient With Breast Carcinoma","authors":"Farzana Shumy, Minhaj Rahim Choudhury, Zahid Amin, Kotaro Matsumoto","doi":"10.1111/1756-185x.70528","DOIUrl":"10.1111/1756-185x.70528","url":null,"abstract":"","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"29 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145846234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flagellate Erythema: An Indicator of Underlying Malignancy in Dermatomyositis 鞭毛状红斑:皮肌炎潜在恶性肿瘤的一个指标。
IF 2 4区 医学 Q2 RHEUMATOLOGY Pub Date : 2025-12-27 DOI: 10.1111/1756-185x.70534
Hieu Chi Ha, On Bon Louis Chan, Anousha Yazdabadi, Christopher Meng Kit Fong
{"title":"Flagellate Erythema: An Indicator of Underlying Malignancy in Dermatomyositis","authors":"Hieu Chi Ha, On Bon Louis Chan, Anousha Yazdabadi, Christopher Meng Kit Fong","doi":"10.1111/1756-185x.70534","DOIUrl":"10.1111/1756-185x.70534","url":null,"abstract":"","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"29 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145846246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deforming Arthritis as a New Rheumatologic Manifestation of Cocaine Use 变形性关节炎是可卡因使用的一种新的风湿病表现。
IF 2 4区 医学 Q2 RHEUMATOLOGY Pub Date : 2025-12-26 DOI: 10.1111/1756-185x.70529
Michael A. Vierra, Amr Edrees
{"title":"Deforming Arthritis as a New Rheumatologic Manifestation of Cocaine Use","authors":"Michael A. Vierra, Amr Edrees","doi":"10.1111/1756-185x.70529","DOIUrl":"10.1111/1756-185x.70529","url":null,"abstract":"","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"29 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145843807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Multifaceted Role of p53 in Musculoskeletal Diseases: A Comprehensive Review p53在肌肉骨骼疾病中的多重作用:综述
IF 2 4区 医学 Q2 RHEUMATOLOGY Pub Date : 2025-12-26 DOI: 10.1111/1756-185x.70523
Marofe Hossain, Sun Hao, Ahamed Yeasin, Yongxiang Wang

Background

While extensively studied for its central role in tumor suppression (regulating cell cycle, DNA repair, and apoptosis), the p53 gene is now recognized for its significant involvement in musculoskeletal diseases. Aberrant p53 expression and function are key factors in the pathogenesis and progression, although the specific mechanisms and clinical change potential remain incompletely defined.

Objective

This review systematically summarizes the multifaceted roles of p53 in major musculoskeletal diseases, analyzes the molecular mechanisms driving disease progression, and evaluates its potential as a therapeutic target.

Methods

A comprehensive literature search was conducted in PubMed January 2008 to March 2025 using keywords including P53, osteoporosis, osteoarthritis, rheumatoid arthritis, gout, low back pain, and scoliosis. Original research, reviews, and clinical trials focusing on p53 mechanisms were included. 90 relevant articles were selected for analysis.

Results & Conclusion

p53 critically influences the development and progression of musculoskeletal diseases (osteoporosis, osteoarthritis, rheumatoid arthritis, low back pain, gout, and scoliosis) through diverse mechanisms: Disrupting bone formation/resorption balance (via the p53-Nedd4-Runx2 axis in osteoporosis). Promoting chondrocyte apoptosis (via the miR-34a-SIRT1-p53 pathway in osteoarthritis). Modulating inflammatory mediators (TNF-α, IL-6 in rheumatoid arthritis). Regulating oxidative stress responses (p53-SLC2A9 axis in gout). p53 exhibits dual roles (pro-apoptotic vs. anti-inflammatory), necessitating precise targeting strategies. Promising therapeutic interventions include p53-focused gene editing (CRISPR/Cas9), small-molecule inhibitors (PFT-α), and natural products (naringin). However, further clinical validation is essential. Future research requires multidisciplinary approaches to deepen understanding of p53 mechanisms and advance clinical applications in musculoskeletal disorders.

背景:虽然p53基因在肿瘤抑制(调节细胞周期、DNA修复和细胞凋亡)中的核心作用被广泛研究,但现在人们认识到它在肌肉骨骼疾病中的重要作用。p53的异常表达和功能是其发病和进展的关键因素,但其具体机制和临床变化潜力尚未完全确定。目的:本文系统总结了p53在主要肌肉骨骼疾病中的多方面作用,分析了其驱动疾病进展的分子机制,并评估了其作为治疗靶点的潜力。方法:在PubMed 2008年1月至2025年3月检索相关文献,检索关键词为P53、骨质疏松症、骨关节炎、类风湿关节炎、痛风、腰痛、脊柱侧凸。原始研究,综述和临床试验集中在p53机制包括。选取90篇相关文章进行分析。结果与结论:p53通过多种机制严重影响肌肉骨骼疾病(骨质疏松症、骨关节炎、类风湿性关节炎、腰痛、痛风和脊柱侧弯)的发生和进展:破坏骨形成/吸收平衡(在骨质疏松症中通过p53- nedd4 - runx2轴)。促进软骨细胞凋亡(通过miR-34a-SIRT1-p53通路在骨关节炎中)。类风湿关节炎中调节炎症介质(TNF-α, IL-6)。调节痛风中的氧化应激反应(p53-SLC2A9轴)。P53表现出双重作用(促凋亡和抗炎),需要精确的靶向策略。有希望的治疗干预措施包括p53靶向基因编辑(CRISPR/Cas9)、小分子抑制剂(PFT-α)和天然产物(柚皮苷)。然而,进一步的临床验证是必要的。未来的研究需要多学科的方法来加深对p53机制的理解,并推进在肌肉骨骼疾病中的临床应用。
{"title":"The Multifaceted Role of p53 in Musculoskeletal Diseases: A Comprehensive Review","authors":"Marofe Hossain,&nbsp;Sun Hao,&nbsp;Ahamed Yeasin,&nbsp;Yongxiang Wang","doi":"10.1111/1756-185x.70523","DOIUrl":"10.1111/1756-185x.70523","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>While extensively studied for its central role in tumor suppression (regulating cell cycle, DNA repair, and apoptosis), the p53 gene is now recognized for its significant involvement in musculoskeletal diseases. Aberrant p53 expression and function are key factors in the pathogenesis and progression, although the specific mechanisms and clinical change potential remain incompletely defined.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This review systematically summarizes the multifaceted roles of p53 in major musculoskeletal diseases, analyzes the molecular mechanisms driving disease progression, and evaluates its potential as a therapeutic target.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A comprehensive literature search was conducted in PubMed January 2008 to March 2025 using keywords including P53, osteoporosis, osteoarthritis, rheumatoid arthritis, gout, low back pain, and scoliosis. Original research, reviews, and clinical trials focusing on p53 mechanisms were included. 90 relevant articles were selected for analysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results &amp; Conclusion</h3>\u0000 \u0000 <p>p53 critically influences the development and progression of musculoskeletal diseases (osteoporosis, osteoarthritis, rheumatoid arthritis, low back pain, gout, and scoliosis) through diverse mechanisms: Disrupting bone formation/resorption balance (via the p53-Nedd4-Runx2 axis in osteoporosis). Promoting chondrocyte apoptosis (via the miR-34a-SIRT1-p53 pathway in osteoarthritis). Modulating inflammatory mediators (TNF-α, IL-6 in rheumatoid arthritis). Regulating oxidative stress responses (p53-SLC2A9 axis in gout). p53 exhibits dual roles (pro-apoptotic vs. anti-inflammatory), necessitating precise targeting strategies. Promising therapeutic interventions include p53-focused gene editing (CRISPR/Cas9), small-molecule inhibitors (PFT-α), and natural products (naringin). However, further clinical validation is essential. Future research requires multidisciplinary approaches to deepen understanding of p53 mechanisms and advance clinical applications in musculoskeletal disorders.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"29 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145843795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic Lupus Erythematosus and Multiple Sclerosis Overlap After Adalimumab Therapy: A Case Report 阿达木单抗治疗后系统性红斑狼疮和多发性硬化症重叠:一例报告。
IF 2 4区 医学 Q2 RHEUMATOLOGY Pub Date : 2025-12-25 DOI: 10.1111/1756-185x.70527
María García-González, Andrea Fernández-Valmaña, Jesús Alberto López-Martínez, Marta Ros-Segura, Carlos Feijoo-Massó
{"title":"Systemic Lupus Erythematosus and Multiple Sclerosis Overlap After Adalimumab Therapy: A Case Report","authors":"María García-González,&nbsp;Andrea Fernández-Valmaña,&nbsp;Jesús Alberto López-Martínez,&nbsp;Marta Ros-Segura,&nbsp;Carlos Feijoo-Massó","doi":"10.1111/1756-185x.70527","DOIUrl":"10.1111/1756-185x.70527","url":null,"abstract":"","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"28 12","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145833932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential Significance of CCL17 in Psoriatic Arthritis CCL17在银屑病关节炎中的潜在意义。
IF 2 4区 医学 Q2 RHEUMATOLOGY Pub Date : 2025-12-23 DOI: 10.1111/1756-185x.70526
Kevin Ming-Chin Lee, Adrian A. Achuthan, Matthew Jiang, John A. Hamilton, Keith Lim
{"title":"Potential Significance of CCL17 in Psoriatic Arthritis","authors":"Kevin Ming-Chin Lee,&nbsp;Adrian A. Achuthan,&nbsp;Matthew Jiang,&nbsp;John A. Hamilton,&nbsp;Keith Lim","doi":"10.1111/1756-185x.70526","DOIUrl":"10.1111/1756-185x.70526","url":null,"abstract":"","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"28 12","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145809871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tocilizumab in the Treatment of Sporadic Inclusion Body Myositis 托珠单抗治疗散发性包涵体肌炎。
IF 2 4区 医学 Q2 RHEUMATOLOGY Pub Date : 2025-12-21 DOI: 10.1111/1756-185x.70521
Cheng Xu, Ning Shen, Yongmei Han
{"title":"Tocilizumab in the Treatment of Sporadic Inclusion Body Myositis","authors":"Cheng Xu,&nbsp;Ning Shen,&nbsp;Yongmei Han","doi":"10.1111/1756-185x.70521","DOIUrl":"10.1111/1756-185x.70521","url":null,"abstract":"","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"28 12","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of Pneumocystis Pneumonia in Patients With Rheumatoid Arthritis and the Role of Prophylactic Salazosulfapyridine 类风湿关节炎患者肺囊虫性肺炎的风险及预防性磺胺吡啶的作用。
IF 2 4区 医学 Q2 RHEUMATOLOGY Pub Date : 2025-12-21 DOI: 10.1111/1756-185x.70516
Ryo Sato, Kenya Terabe, Takahiro Imaizumi, Koji Sakamoto, Kikue Sato, Junya Hasegawa, Takaya Sugiura, Yusuke Ono, Mochihito Suzuki, Shuji Asai, Shiro Imagama

Objectives

This study aimed to assess the risk factors for Pneumocystis pneumonia (PCP) in patients with rheumatoid arthritis (RA) and investigate the potential of salazosulfapyridine (SASP) as a prophylactic agent.

Methods

The present study analyzed data from the Japanese Diagnosis Procedure Combination database, which provides comprehensive inpatient data (including diagnoses, procedures, and medications) covering a large portion of the population. We identified patients with RA who developed PCP among 14 190 patients diagnosed with RA at admission with a treatment history. Patients with RA who were receiving therapeutic doses of drugs for PCP were defined as having PCP. A nested case–control analysis was performed to compare patients with RA and PCP with age- and sex-matched control patients with RA without PCP in a ratio of 1:20.

Results

The cohort comprised 132 patients with PCP and 2575 controls. The risk factors for PCP in RA were chronic obstructive pulmonary disease, methotrexate (MTX), biological/targeted synthetic DMARDs (b/tsDMARDs), and high-dose glucocorticoids. SASP may have a protective effect against PCP, particularly in patients with RA treated with MTX and/or b/tsDMARDs.

Conclusion

The large sample size of the present study suggests that SASP may be associated with a reduced PCP risk in RA patients.

目的:本研究旨在评估类风湿关节炎(RA)患者肺囊虫性肺炎(PCP)的危险因素,并探讨salazosulfapyridine (SASP)作为预防药物的潜力。方法:本研究分析了来自日本诊断程序组合数据库的数据,该数据库提供了涵盖大部分人口的全面住院数据(包括诊断,程序和药物)。我们在14190名入院时有治疗史的RA患者中发现了出现PCP的RA患者。接受PCP治疗剂量的RA患者被定义为PCP患者。进行巢式病例对照分析,将RA和PCP患者与年龄和性别匹配的RA无PCP对照患者以1:20的比例进行比较。结果:该队列包括132例PCP患者和2575例对照。慢性阻塞性肺疾病、甲氨蝶呤(MTX)、生物/靶向合成DMARDs (b/tsDMARDs)和大剂量糖皮质激素是RA中PCP的危险因素。SASP可能对PCP有保护作用,特别是在接受MTX和/或b/tsDMARDs治疗的RA患者中。结论:本研究的大样本量表明SASP可能与RA患者PCP风险降低有关。
{"title":"Risk of Pneumocystis Pneumonia in Patients With Rheumatoid Arthritis and the Role of Prophylactic Salazosulfapyridine","authors":"Ryo Sato,&nbsp;Kenya Terabe,&nbsp;Takahiro Imaizumi,&nbsp;Koji Sakamoto,&nbsp;Kikue Sato,&nbsp;Junya Hasegawa,&nbsp;Takaya Sugiura,&nbsp;Yusuke Ono,&nbsp;Mochihito Suzuki,&nbsp;Shuji Asai,&nbsp;Shiro Imagama","doi":"10.1111/1756-185x.70516","DOIUrl":"10.1111/1756-185x.70516","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This study aimed to assess the risk factors for <i>Pneumocystis</i> pneumonia (PCP) in patients with rheumatoid arthritis (RA) and investigate the potential of salazosulfapyridine (SASP) as a prophylactic agent.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The present study analyzed data from the Japanese Diagnosis Procedure Combination database, which provides comprehensive inpatient data (including diagnoses, procedures, and medications) covering a large portion of the population. We identified patients with RA who developed PCP among 14 190 patients diagnosed with RA at admission with a treatment history. Patients with RA who were receiving therapeutic doses of drugs for PCP were defined as having PCP. A nested case–control analysis was performed to compare patients with RA and PCP with age- and sex-matched control patients with RA without PCP in a ratio of 1:20.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The cohort comprised 132 patients with PCP and 2575 controls. The risk factors for PCP in RA were chronic obstructive pulmonary disease, methotrexate (MTX), biological/targeted synthetic DMARDs (b/tsDMARDs), and high-dose glucocorticoids. SASP may have a protective effect against PCP, particularly in patients with RA treated with MTX and/or b/tsDMARDs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The large sample size of the present study suggests that SASP may be associated with a reduced PCP risk in RA patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"28 12","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Rheumatic Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1